Anterior Ischemic Optic Neuropathy
📧 Sign up to get email alerts when something new happens for Anterior Ischemic Optic Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
A clinical trial evaluating the diagnostic accuracy of optimized diffusion-weighted imaging for detecting anterior ischemic optic neuropathy…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Optic Nerve Sheath Ultrasound in Giant Cell Arteritis
A clinical trial is currently recruiting to evaluate the use of optic nerve sheath ultrasound in patients with giant cell arteritis and rela…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Optic Nerve Head Evaluation Through Multimodal Blood Flow Analysis: a Prospective Observational, Multi-center Study
A prospective, multi-center observational trial evaluating optic nerve head blood flow using multimodal imaging in neuro-ophthalmic conditio…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Visual Involvement in Giant Cell Arteritis
A clinical trial update indicates a study on visual involvement in giant cell arteritis is currently recruiting, focusing on ocular complica…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) [Phase 4]
Phase 4 trial evaluating PDE5 inhibitor use and non-arteritic anterior ischemic optic neuropathy was terminated with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-03-31Clinical Trial Update: Effect of EECP on Anterior Ischemic Optic Neuropathy [NA]
A clinical trial is investigating the effect of Enhanced External Counterpulsation on anterior ischemic optic neuropathy, with no current st…
-
CLINICAL_TRIALS withdrawal · 2015-05-25Clinical Trial Update: Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% [Phase 1]
Phase 1 study evaluating ophthalmic timolol maleate 0.5% for ischemic optic neuropathy has been withdrawn. The reported conditions include i…